Le Lézard
Classified in: Science and technology
Subjects: Conference, Event

VOICE & AI 2023 Launches with Top LLMs and Major Brands Sharing the Future of Conversational and Generative AI


Artificial Intelligence (AI) is reshaping how Fortune 500 companies operate, and the stories behind that transformation reveal the boundless opportunities of generative and conversational AI technologies.

Verizon and Amazon Web Services (AWS) are the latest to join VOICE & AI, the leading natural language and generative AI event, to share their stories of AI's potential. Held this week on September 5-7, 2023 at the Washington Hilton in Washington D.C., VOICE & AI promises to be one of the largest gatherings of leading experts in the field.

Foundational large language models (LLMs), leading AI tools, and Fortune 500 brands will educate attendees, demonstrate successes in leveraging AI, and illuminate the path forward for artificial intelligence. Sponsors and speakers include brands and executives from companies such as OpenAI, NVIDIA, Walmart, GM, Veritone, J.P. Morgan, and KoreAI. The latest speakers include:

"VOICE & AI 2023 is not just a conference ? it's an immersive experience designed to connect and empower enterprise leaders, developers, researchers, and policymakers," said Pete Erickson, CEO of Modev and organizer of VOICE & AI 2023, "Having such recognizable brands step forward to join VOICE & AI and share their vision for the potential of AI underscores how far-reaching the possibilities are for companies in every industry."

VOICE & AI 2023's speaker lineup of more than 150 speakers from around the world ensures attendees will gain invaluable insights into the future of generative and conversational AI. The event begins with hands-on workshops, followed by two days of talks, panels and presentations, including keynotes from leading companies in the AI space, as well as interactive demos, an exhibit hall featuring some of the top brands in conversational and generative AI, and meetups and receptions for networking and knowledge sharing.

Tickets for VOICE & AI 2023 are still available.

About Modev
Modev is a leading organization dedicated to fostering growth, innovation, and collaboration in the artificial intelligence and sustainable tech communities. With a strong focus on generative AI, VOICE & AI is Modev's keystone AI event, bringing together the brightest minds in the field to advance the development and application of AI technology on a global scale. The company is also launching GovAI Summit in December hosting hundreds of public sector AI leaders from across government, education and the non-profit sectors. To learn more about Modev, and the breadth of events offered live and virtually, visit Modev's website and join Modev on LinkedIn, Twitter, Facebook, and YouTube.


These press releases may also interest you

at 21:09
On June 29, the "Gather Great Wisdom to Shape the Future of Intelligent Manufacturing?Special Exhibition on Design Intelligence and High Quality Development", hosted by the China Academy of Art (CAA), opened at the National Museum of China in...

at 20:55
Intermap Technologies ("Intermap" or the "Company"), a global leader in 3D geospatial products and intelligence solutions, announces a new financing. The Company is offering up to a maximum of 4,300,000 Class "A" common shares of the Company...

at 20:45
"The Classic Quotes by Xi Jinping," a multilingual TV show produced by China Media Group, aired in Kazakhstan on Tuesday after Chinese...

at 20:07
Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in discovering, developing and commercializing both first-in-class and best-in-class therapies for hematological malignancies, announced today that on July 2, 2024, in relation to...

at 20:05
Enterprises in Asia Pacific are moving toward software-defined networking (SDN) to make communication more secure and resilient and speed up business decision-making, according to a new research report published today by Information Services Group...

at 20:00
Atara Biotherapeutics, Inc. , a leader in T-cell immunotherapy, leveraging its novel allogeneic Epstein-Barr virus (EBV) T-cell platform to develop transformative therapies for patients with cancer and autoimmune diseases, today announced that Pascal...



News published on and distributed by: